Dog blev de personer, som forud for vaccination allerede havde en infektion med en vaccinerelateret HPV- type, beskyttet mod kliniske sygdomme forårsaget af de øvrige HPV- typer.
However, individuals already infected with one of the vaccine- related HPV types prior to vaccination were protected from clinical disease caused by the remaining HPV type.